Ligand Release Offers Highlights from Analyst Day: Expecting FY15 Sales in $81-$83M Range vs $91.9M Est., Sees FY16 Sales Exceeding $107M, Adj. EPS Exceeding $3.20, Sees FY17 Sales Exceeding $146M, Adj. EPS Exceeding $4.65
Paul Quintaro